2230 Stock Overview
Saudi Chemical Holding Company manufacture, wholesale, and retail trade of medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools and equipment in the Kingdom of Saudi Arabia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Saudi Chemical Holding Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س7.81 |
| 52 Week High | ر.س8.37 |
| 52 Week Low | ر.س2.94 |
| Beta | 0.46 |
| 1 Month Change | 9.38% |
| 3 Month Change | 64.08% |
| 1 Year Change | 160.77% |
| 3 Year Change | 107.99% |
| 5 Year Change | 214.60% |
| Change since IPO | 292.34% |
Recent News & Updates
With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case
Mar 06
Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors
Feb 10Recent updates
With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case
Mar 06Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors
Feb 10Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return
Oct 31Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today
Jul 06Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50
Jan 09Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50
Dec 22Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital
Sep 14Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around
Dec 06Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?
Apr 19Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital
Mar 29Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?
Mar 01Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?
Feb 01
How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?
Dec 28Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?
Nov 30Shareholder Returns
| 2230 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | 6.8% | -1.1% | -1.3% |
| 1Y | 160.8% | 20.7% | 0.4% |
Return vs Industry: 2230 exceeded the SA Healthcare industry which returned 20.7% over the past year.
Return vs Market: 2230 exceeded the SA Market which returned 0.4% over the past year.
Price Volatility
| 2230 volatility | |
|---|---|
| 2230 Average Weekly Movement | 8.5% |
| Healthcare Industry Average Movement | 4.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in SA Market | 8.0% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 2230's share price has been volatile over the past 3 months.
Volatility Over Time: 2230's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of SA stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1972 | n/a | Thamer Al-Muhaid | www.saudichemical.com |
Saudi Chemical Holding Company manufacture, wholesale, and retail trade of medicines, medical materials and syrups, pharmaceutical preparations, medical and surgical tools and equipment in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Explosive; Medicine and Medical Supplies; and Production of Ammonium Nitrate. It also manufactures and sells explosives and related products for civil and military uses, as well as hospitals and medical centers supplies and related spare parts, and food items; and manufacture of ammonium nitrate, as well as provides technical support services in explosions.
Saudi Chemical Holding Company Fundamentals Summary
| 2230 fundamental statistics | |
|---|---|
| Market cap | ر.س6.59b |
| Earnings (TTM) | ر.س182.89m |
| Revenue (TTM) | ر.س4.85b |
36.0x
P/E Ratio1.4x
P/S RatioIs 2230 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2230 income statement (TTM) | |
|---|---|
| Revenue | ر.س4.85b |
| Cost of Revenue | ر.س4.18b |
| Gross Profit | ر.س671.44m |
| Other Expenses | ر.س488.56m |
| Earnings | ر.س182.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.22 |
| Gross Margin | 13.83% |
| Net Profit Margin | 3.77% |
| Debt/Equity Ratio | 66.9% |
How did 2230 perform over the long term?
See historical performance and comparison